Verismo Therapeutics Announces Strategic Partnership with IFLI to Support SynKIR™-310 Development in Follicular Lymphoma Verismo will receive up to $4.05 million USD in investments from the… CISION PRNewswireJanuary 7, 2025
GORTEC Announces New Trial Success for Head and Neck Cancer Treatment TOURS, France, Jan. 7, 2025 /PRNewswire/ — GORTEC, known as Head and… CISION PRNewswireJanuary 7, 2025
Press ReleaseMoomoo Announces Global Partnership With Seeking Alpha to Amplify Trading Potential for Investors JERSEY CITY, N.J., Jan. 7, 2025 /PRNewswire/ — Moomoo, one of the… CISION PRNewswireJanuary 7, 2025
Press ReleaseSegway Officially Recognized as Global No.1 Brand in eKickScooter Sales Micromobility leader announces verified milestone as it debuts new models during CES… CISION PRNewswireJanuary 7, 2025
Press ReleaseMega Matrix Inc. Attended China-UAE Industry and Investment Cooperation Conference to Further Deepen Middle East Short Drama Strategy SINGAPORE, Jan. 7, 2025 /PRNewswire/ — Mega Matrix Inc. (NYSE American: MPU) announced… CISION PRNewswireJanuary 7, 2025
Press ReleaseConcept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment TAMPA, Fla., Jan. 7, 2025 /PRNewswire/ — Concept Medical Inc., a global… CISION PRNewswireJanuary 7, 2025
Eyebright Medical Receives NMPA Class III Certificate for its Phakic Intraocular Lens HONG KONG, Jan. 7, 2025 /PRNewswire/ — Eyebright Medical Technology (Beijing) Co.,… CISION PRNewswireJanuary 7, 2025
Corero Network Security Achieves 16% ARR Growth, Driving Momentum into 2025 Record $19.5M ARR and strong order growth cement Corero’s leadership in SaaS-driven… CISION PRNewswireJanuary 7, 2025